3 Ways Biotechs Can Lower The Cost Of Trials, Tips For Selecting Clinical Technology, and More

Welcome to the Clinical Trial Insights newsletter, featuring strategic insights and expert opinions on designing and running clinical trials. Each edition covers the latest trending articles on ClinicalLeader.com.

In this week's issue, we'll review 3 ways biotechs can lower the cost of clinical trials, tips for selecting clinical technology, how patient tokenization can streamline trials, why sites aren't moving to eSource, and other popular insights.

If you like what you're seeing in our condensed LinkedIn editions, subscribe to our daily newsletter for full access to exclusive articles, webinars, e-books, and more! Subscribe Now →

TOP 5 READS OF THE PAST WEEK

#1 3 Ways Biotechs Can Lower The Cost Of Clinical Trials

The clinical trial stage is challenging to many startups and scaleups, not least because of the costs. LongeVC has identified three innovative models to help biotechs lower the cost of their clinical trials.

READ NOW →

#2 The Key To Clinical Trial Success: Patient Tokenization

Komodo Health shares how utilizing connected, robust, and reliable patient population insights, real-world data and patient tokenization can streamline clinical trials and guarantee successful outcomes.

READ NOW →

#3 Quick Tips And Hot Takes For Selecting Clinical Trial Technology

Avoid inefficient decision-making that keeps key downstream activities in limbo and select a new clinical trial technology efficiently with this technology selection guide by Monica R. .

READ NOW →

#4 Why Aren't More Sites Moving To eSource?

In this segment, Techfields Inc. “A Pharma Company" 's Robert S. Goldman talks about different views of what eSource is and how, in some instances, this clinical trial technology doesn’t save any time over using paper.

READ NOW →

#5 FDA Guidance On Standardizing Diversity And Inclusion Terminology And Collection

The FDA recently issued a new draft guidance titled Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products. Deborah Livornese provides an overview.

READ NOW →

MORE TO EXPLORE

• What Does The New FDA DHT Guidance Mean? A Practical Guide For Sponsors
• Is Being Competent And Qualified The Same Thing In The GCP World?
• Implications Of FDA’s Final Guidance On Informed Consent
• 3 Areas Where AI Could Revolutionize Patient Recruitment And Retention
• Mitigating The Risks Of Long-Term Oncology eCOA Clinical Trials

Simplify clinical trials today. Transform for the future with Zelta.

Join our webinar with?Zelta by Merative?on February 22nd to hear common challenges facing sponsors and how to prepare for the future of your trial portfolio.?See what is top of mind from peers and what Zelta is doing to meet those needs in the market.

RESERVE YOUR SPOT →

Clinical Leader is an online community serving professionals in the clinical research space. We share insights and best practices — from industry experts — to help sponsors and CROs tackle the biggest challenges they face in designing and running clinical trials.

To get the most out of our offerings, join the Clinical Leader community.